Mimetics Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mimetics company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mimetics Company Profile Today - Breaking & Trending Today

GlycoMimetics (NASDAQ:GLYC) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of GlycoMimetics (NASDAQ:GLYC – Get Rating) in a research report issued on Friday. The brokerage set a “hold” rating on the biotechnology company’s stock. Separately, Zacks Investment Research upgraded GlycoMimetics from a “hold” rating to a “buy” rating and set a $0.75 price target on the stock in a research […] ....

United States , Geode Capital Management , Glycomimetics Inc , Acadian Asset Management , Zacks Investment Research , Millennium Management , Glycomimetics Company Profile Get Rating , Get Rating , Asset Management , Sigma Investments , Capital Management , Mimetics Company Profile , Nasdaq Glyc , Initiated Coverage , Stocknews Com ,

GlycoMimetics (NASDAQ:GLYC) and Nature's Sunshine Products (NASDAQ:NATR) Head to Head Survey

GlycoMimetics (NASDAQ:GLYC – Get Rating) and Nature’s Sunshine Products (NASDAQ:NATR – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability. Analyst Ratings This is a breakdown of recent ratings […] ....

United States , Nature Sunshine Products Inc , National Cancer Institute , Apollomics Hong Kong , Nature Sunshine Products Company Profile Get Rating , Nature Sunshine Products , Glycomimetics Inc , Glycomimetics Company Profile Get Rating , Get Rating , Sunshine Products , Given Glycomimetic , Sunshine Product , Mimetics Company Profile , Hong Kong , Sunshine Products Company Profile , North America , Latin America , Synergy Worldwide , Nasdaq Glyc , Stock Comparison , Stock Analysis ,

GlycoMimetics (NASDAQ:GLYC) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of GlycoMimetics (NASDAQ:GLYC – Get Rating) in a report issued on Thursday. The firm set a “hold” rating on the biotechnology company’s stock. Shares of NASDAQ:GLYC opened at $1.07 on Thursday. The company has a market capitalization of $55.98 million, a P/E ratio of -0.87 and a beta of 1.82. […] ....

Glycomimetics Inc , Goldman Sachs Group Inc , Acadian Asset Management , Millennium Management , Glycomimetics Company Profile Get Rating , Capital Partners , Get Rating , Sachs Group , Asset Management , Mimetics Company Profile , Nasdaq Glyc , Initiated Coverage , Stocknews Com ,